Citations (45)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Ramón Cacabelos. (2020) Pharmacogenetic considerations when prescribing cholinesterase inhibitors for the treatment of Alzheimer’s disease. Expert Opinion on Drug Metabolism & Toxicology 16:8, pages 673-701.
Read now
Read now
Robert F. Fricke, Irwin Koplovitz, Bruce A. Scharf & Gary A. Rockwood. (1994) Efficacy of Tacrine as a Nerve Agent Pretreatment. Drug and Chemical Toxicology 17:1, pages 15-34.
Read now
Read now
Articles from other publishers (43)
Manickam Selvaraj & Mohammed A. Assiri. (2020) Highly Selective Synthesis of Octahydroaminoacridine over Mesoporous ZnAlMCM-41 Catalysts. Industrial & Engineering Chemistry Research 59:33, pages 14703-14709.
Crossref
Crossref
V. Hepnarova, J. Korabecny, L. Matouskova, P. Jost, L. Muckova, M. Hrabinova, N. Vykoukalova, M. Kerhartova, T. Kucera, R. Dolezal, E. Nepovimova, K. Spilovska, E. Mezeiova, N.L. Pham, D. Jun, F. Staud, D. Kaping, K. Kuca & O. Soukup. (2018) The concept of hybrid molecules of tacrine and benzyl quinolone carboxylic acid (BQCA) as multifunctional agents for Alzheimer's disease. European Journal of Medicinal Chemistry 150, pages 292-306.
Crossref
Crossref
Martin Horak, Kristina Holubova, Eugenie Nepovimova, Jan Krusek, Martina Kaniakova, Jan Korabecny, Ladislav Vyklicky, Kamil Kuca, Ales Stuchlik, Jan Ricny, Karel Vales & Ondrej Soukup. (2017) The pharmacology of tacrine at N -methyl- d -aspartate receptors. Progress in Neuro-Psychopharmacology and Biological Psychiatry 75, pages 54-62.
Crossref
Crossref
Bevyn Jarrott. (2017) Tacrine: In vivo veritas. Pharmacological Research 116, pages 29-31.
Crossref
Crossref
James M. Mutunga, Dhana Raj Boina, Troy D. Anderson, Jeffrey R. Bloomquist, Paul R. Carlier, Dawn M. Wong, Polo C.-H. Lam & Maxim. M. Totrov. (2013)
NEUROTOXICOLOGY OF
bis
(
n
)-TACRINES ON
Blattella germanica
AND
Drosophila melanogaster
ACETYLCHOLINESTERASE
. Archives of Insect Biochemistry and Physiology 83:4, pages 180-194.
Crossref
Crossref
Shanmugavel Uma Maheswari, Subbu Perumal & Abdulrahman I. Almansour. (2012) A facile regio- and stereoselective synthesis of novel dispirooxindolyl-[acridine-2′,3-pyrrolidine/thiapyrrolizidine]-1′-ones via 1,3-dipolar cycloaddition of azomethine ylides. Tetrahedron Letters 53:3, pages 349-353.
Crossref
Crossref
George Deenichin, Atanas Kristev, Vesselin Mollov & Valentin Turiiski. (2010) Effect of Elevated Intra-Abdominal Pressure on the Contractile Activity and Reactivity of Smooth Muscle Tissue from Rat Gastrointestinal Tract to Galantamine and Drotaverine (No-SPA). Folia Medica 52:3.
Crossref
Crossref
Y.-H. Chen, C.-H. Lin, P.-L. Lin & M.-C. Tsai. (2006) Cocaine elicits action potential bursts in a central snail neuron: The role of delayed rectifying K+ current. Neuroscience 138:1, pages 257-280.
Crossref
Crossref
S. Bollo, L. Muñoz, L. J. Núñez-Vergara & J. A. Squella. (2000) Electrochemical Characterization of Tacrine, an Antialzheimer's Disease Drug, and Its Determination in Pharmaceuticals. Electroanalysis 12:5, pages 376-382.
Crossref
Crossref
Derek Kraliz & Satpal Singh. (1997) Selective blockade of the delayed rectifier potassium current by tacrine inDrosophila. Journal of Neurobiology 32:1, pages 1-10.
Crossref
Crossref
ABDULAZIZ A. AL-JAFARI. (1996) The Nature of the Inhibition of Camel Retina Acetylcholinesterase (EC 3.1.1.7) Activity by Tetrahydroaminoacridine. Journal of Ocular Pharmacology and Therapeutics 12:4, pages 503-514.
Crossref
Crossref
J.G. Shaddock, R.J. Feuers, M.W. Chou, D.H. Swenson & D.A. Casciano. (1995) Genotoxicity of tacrine in primary hepatocytes isolated from B6C3F1 mice and aged ad libitum and calorie restricted Fischer 344 rats. Mutation Research/Genetic Toxicology 344:1-2, pages 79-88.
Crossref
Crossref
Haruyuki Chaki, Haruko Yamabe, Mamoru Sugano, Shuji Morita, Tomoko Bessho, Reiko Tabata, Ken-Ichi Saito, Mitsuo Egawa, Akihiro Tobe & Yasuhiro Morinaka. (1995) Design and syntheses of 4-acylaminopyridine derivatives: Novel high affinity choline uptake enhancers II. Bioorganic & Medicinal Chemistry Letters 5:14, pages 1495-1500.
Crossref
Crossref
Hisayoshi Niigawa, Satoshi Tanimukai, Masatoshi Takeda, Shiro Hariguchi & Tsuyoshi Nishimura. (1995) Effects of SDZ ENA 713, novel acetyl cholinesterase inhibitor, on learning of rats with basal forebrain lesions. Progress in Neuro-Psychopharmacology and Biological Psychiatry 19:1, pages 171-186.
Crossref
Crossref
Jeyananthan Chelliah, J.Doyle Smith & Marc W. Fariss. (1994) Inhibition of cholinesterase activity by tetrahydroaminoacridine and the hemisuccinate esters of tocopherol and cholesterol. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology 1206:1, pages 17-26.
Crossref
Crossref
Vladimir S. Vorobjev & Irina N. Sharonova. (1994) Tetrahydroaminoacridine blocks and prolongs NMDA receptor-mediated responses in a voltage-dependent manner. European Journal of Pharmacology 253:1-2, pages 1-8.
Crossref
Crossref
M. Mahjour, B.E. Mauser, Z.A. Rashidbaigi & M.B. Fawzi. (1993) Effects of propylene glycol diesters of caprylic and capric acids (Miglyol® 840) and ethanol binary systems on in vitro skin permeation of drugs. International Journal of Pharmaceutics 95:1-3, pages 161-169.
Crossref
Crossref
C.H. Vanderwolf, Angela Raithby, Melissa Snider, Carolina Cristi & Carolyn Tanner. (1993) Effects of some cholinergic agonists on neocortical slow wave activity in rats with basal forebrain lesions. Brain Research Bulletin 31:5, pages 515-521.
Crossref
Crossref
Abdu Adem. (1992) Putative mechanisms of action of tacrine in Alzheimer's disease. Acta Neurologica Scandinavica 85:S139, pages 69-74.
Crossref
Crossref
Siyu Liu & Diane M. Sylvester. (1992) The inhibitory effect of 9-amino-1,2,3,4-tetrahydroacridine (THA) on platelet function. Thrombosis Research 67:5, pages 533-544.
Crossref
Crossref
Vlad E. Gregor, Mark R. Emmerling, Chitase Lee & Catherine J. Moore. (1992) The synthesis and in vitro acetylcholinesterase and butyrylcholinesterase inhibitory activity of tacrine (Cognex®) derivaties. Bioorganic & Medicinal Chemistry Letters 2:8, pages 861-864.
Crossref
Crossref
C.A. Truman, J.M. Ford & C.J.C. Roberts. (1991) Comparison of the chromatographie characteristics of metabolites of tacrine hydrochloride in human serum and urine with those of in vitro metabolic products from hepatic microsomes. Biochemical Pharmacology 42:4, pages 956-959.
Crossref
Crossref
Shirley E. Freeman & R.M. Dawson. (1991) Tacrine: A pharmacological review. Progress in Neurobiology 36:4, pages 257-277.
Crossref
Crossref
Serge Gauthier & Louise Gauthier. 1991. Cholinergic Basis for Alzheimer Therapy. Cholinergic Basis for Alzheimer Therapy
224
230
.
Bo R. Holmstedt & Ingrid Nordgren. 1991. Cholinergic Basis for Alzheimer Therapy. Cholinergic Basis for Alzheimer Therapy
155
161
.
A. Adem, A. K. Mohammed & B. Winblad. (1990) Multiple effects of tetrahydroaminoacridine on the cholinergic system: Biochemical and behavioural aspects. Journal of Neural Transmission - Parkinson's Disease and Dementia Section 2:2, pages 113-128.
Crossref
Crossref
A. Sattin, B.B. Muhoberac, M.H. Aprison & C.L. Schauf. (1989) Tetrahydroaminoacridine (THA) as a pharmacological probe in Alzheimer's disease (AD) and other neurodegenerative disorders. Medical Hypotheses 29:3, pages 155-159.
Crossref
Crossref
Howard P. Hendrickson, Dennis O. Scott & Craig E. Lunte. (1989) Identification of 9-hydroxylamine-1,2,3,4-tetrahydroacridine as a hepatic microsomal metabolite of tacrine by high-performance liquid chromatography and electrochemistry. Journal of Chromatography B: Biomedical Sciences and Applications 487, pages 401-408.
Crossref
Crossref
Shirley Estelle Freeman, Wai-Man Lau & Maria Szilagyi. (1988) Blockade of a cardiac K+ channel by tacrine: interactions with muscarinic and adenosine receptors. European Journal of Pharmacology 154:1, pages 59-65.
Crossref
Crossref
Toshitaka Nabeshima, Shigeru Yoshida & Tsutomu Kameyama. (1988) Effects of the novel compound NIK-247 on impairment of passive avoidance response in mice. European Journal of Pharmacology 154:3, pages 263-269.
Crossref
Crossref
Andrew H. Tang & Stanley R. Franklin. (1988) Discriminative stimulus properties of physostigmine in rats. European Journal of Pharmacology 153:1, pages 97-104.
Crossref
Crossref
Bradley D. Pearce & Lincoln T. Potter. (1988) Effects of tetrahydroaminoacridine on M1 and M2 muscarine receptors. Neuroscience Letters 88:3, pages 281-285.
Crossref
Crossref
D.R. Forsyth, J.M. Ford, C.A. Truman, C.J.C. Roberts & G.K. Wilcock. (1988) Determination of tacrine hydrochloride in human serum by chloroform extraction, reversed-phase high-performance liquid chromatography and fluorimetric detection. Journal of Chromatography B: Biomedical Sciences and Applications 433, pages 352-358.
Crossref
Crossref
L. Jaime Fitten, Kent Perryman, Kenneth Tachiki & Arthur Kling. (1988) Oral tacrine administration in middle-aged monkeys: Effects on discrimination learning. Neurobiology of Aging 9, pages 221-224.
Crossref
Crossref
M. Marta, C. Castellano, A. Oliverio, F. Pavone, P.G. Pagella, M. Brufani & M. Pomponi. (1988) New analogs of physostigmine: Alternative drugs for Alzheimer's disease?. Life Sciences 43:23, pages 1921-1928.
Crossref
Crossref
B. Drukarch, J.E. Leysen & J.C. Stoof. (1988) Further analysis of the neuropharmacological profile of 9-amino-1,2,3,4-tetrahydroacridine (THA), an alleged drug for the treatment of Alzheimer's disease. Life Sciences 42:9, pages 1011-1017.
Crossref
Crossref
David R. Webb, Vijendra KR. Singh, H. Hugh Fudenberg, Roger W. Russell, L. Öhman, G. Maluszynska, K.-E. MAgnusson, O. Stendahl, Peter A. Lambert, David H. P. Streeten, Gunnar H. Anderson, Vickram Ramkumar, George Pierson, Gary L. Stiles, Bernard Testa, Joachm M. Mayer, Duncan Stewart-Tull, Michael Williams, Gary L. Niel, Peter Hambleton, Stephen D. Prior, Andrew Robinson, Jed F. Fisher & Paul A. AristoffRoger W. Russell. 1988. Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques. Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques
43
130
.
Benjamin Drukarch, Karel S. Kits, Eric G. Van der Meer, Johannes C. Lodder & Johannes C. Stoof. (1987) 9-Amino-1,2,3,4-tetrahydroacridine (THA), an alleged drug for the treatment of Alzheimer's disease, inhibits acetylcholinesterase activity and slow outward K+ current. European Journal of Pharmacology 141:1, pages 153-157.
Crossref
Crossref
David R. Stevens & Carl W. Cotman. (1987) Excitatory actions of tetrahydro-9-aminoacridine (THA) on hippocampal pyramidal neurons. Neuroscience Letters 79:3, pages 301-305.
Crossref
Crossref
. (1987) Cholinergic Treatment in Alzheimer's Disease: Encouraging Results. The Lancet 329:8525, pages 139-141.
Crossref
Crossref
Thomas H. Park, Ken H. Tachiki, William K. Summers, David Kling, Jaime Fitten, Kent Perryman, Karen Spidell & Arthur S. Kling. (1986) Isolation and the fluorometric, high-performance liquid chromatographic determination of tacrine. Analytical Biochemistry 159:2, pages 358-362.
Crossref
Crossref
William Koopmans Summers, Lawrence Victor Majovski, Gary Martin Marsh, Kenneth Tachiki & Arthur Kling. (1986) Oral Tetrahydroaminoacridine in Long-Term Treatment of Senile Dementia, Alzheimer Type. New England Journal of Medicine 315:20, pages 1241-1245.
Crossref
Crossref
John Y.K. Hsieh, R.K. Yang & Kenneth L. Davis. (1983) High-performance liquid chromatographic determination of tetrahydroaminoacridine in human and rat tissues using a rapid Sep-Pak C18 extraction. Journal of Chromatography B: Biomedical Sciences and Applications 274, pages 388-392.
Crossref
Crossref